DAY 2

Day 2: Tuesday, August 19, 2014

Session 3: Potential for Animal Biotechnologies in Different Sectors

        Potential impact of animal biotechnology on food and economic security in developing economies (Steve Kemp, Kenya)

        Animal Industry Perspectives on Animal Biotechnology:

• • Biotechnology investment (David Thorbahn, US)

  • Genetically engineered models of disease (John Swart, US)

Session 4: Technology and Science-directed Regulation

         Panel: Science-based regulations and challenges associated with animal biotechnologies

• • Using science to inform risk assessment and regulation (Eric Hallerman, US)

  • Canadian Assessment of Foods and Feeds derived from rDNA animals: teamwork approach (Luc Bourbonniere, Canada)

  • Regulatory frameworks from an emerging economy perspective: Indian regulatory approach to biotechnologies (S.R. Rao, India)

  • Technology and science-directed regulation: Product-based vs. process-based regulation (Harlan Howard, Brinda Dass, and Larisa Rudenko, US)

  • Food animals versus public health applications (Maria Lucia Zaidan Dagli, Brazil)

  • Environmental Risk Assessment for release of animals developed via biotechnology in Canada (Jim Louter, Canada)

         What can we learn from 20 years of genomic research regarding the risk of modifying genomes? (Perry Hackett, US)

Session 5: Case Studies: Regulatory experiences with GE animals and insects

        Panel - GE mosquito (Regulatory process, communication with public, lessons learned):

• • Genetically engineered self-limiting Aedes aegypti mosquito (Beech and Gianoto, UK)

  • The Aedes transgenic project (Margareth de Lara Capurro-Guimaraes, Brazil)

  • Malaysian experiences with transgenic mosquito (Letchtummanan Ramatha, Malaysia)

  • Regulatory experience with the GE mosquito release in Panama (Judith Ivette Vargas, Panama)

         Panel - GE salmon (Coordination among regulatory agencies in different countries, challenges in the process, lessons learned):

• •  AquAdvantage salmon (Ron Stottish, US)

  •  Regulatory process of the GE salmon development in Panama (Judith Ivette Vargas, Panama)

  •  GE salmon oversight in Canada (Jim Louter, Canada)

         Concurrent Sessions (breakout dialogs)

• • Advancing opportunities for harmonization

  • Building coalitions within the animal biotechnology sector to affect change

  • Capacity building needs for emerging markets/less developed regulatory systems